ConductScience.org, home

Paper8201642

A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.

Smith JA. J Urol, 1994. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate. Papers, record 8201642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8201642

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate.
PubMed
Journal
J Urol
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2022-03-18
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Smith JA JrJ A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ClonidineMajor topic
DiethylstilbestrolMajor topic
ErgotamineMajor topic
FlushingMajor topic
MegestrolMajor topic
PhenobarbitalMajor topic
Prostatic NeoplasmsMajor topic
Aged
Androgen Antagonists
Gonadotropin-Releasing Hormone
Humans
Male
Megestrol Acetate
Orchiectomy

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
42542970Treatment of Hot Flashes in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy.Prostate2026https://conductscience.org/library/papers/42542970PubMed
31367069The resurgence of estrogens in the treatment of castration-resistant prostate cancer.Indian J Urol2019https://conductscience.org/library/papers/31367069PubMed
29928703Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results from a single institution experience.Clin Transl Radiat Oncol2018https://conductscience.org/library/papers/29928703PubMed
26648754Optimal delivery of male breast cancer follow-up care: improving outcomes.Breast Cancer (Dove Med Press)2015https://conductscience.org/library/papers/26648754PubMed
24864213Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer.Prostate Cancer2014https://conductscience.org/library/papers/24864213PubMed
22286861Androgen deprivation therapy-associated vasomotor symptoms.Asian J Androl2012https://conductscience.org/library/papers/22286861PubMed
20494414Acupuncture for hot flashes in patients with prostate cancer.Urology2010https://conductscience.org/library/papers/20494414PubMed
18231613Estrogenic side effects of androgen deprivation therapy.Rev Urol2007https://conductscience.org/library/papers/18231613PubMed
16985883Adverse events associated with hormonal therapy for prostate cancer.Rev Urol2005https://conductscience.org/library/papers/16985883PubMed
15869726Preventing and treating the complications of hormone therapy.Curr Urol Rep2005https://conductscience.org/library/papers/15869726PubMed
11057778'Hot flush', an unpleasant symptom accompanying antiandrogen therapy of prostatic cancer and its treatment by cyproterone acetate.Int Urol Nephrol2000https://conductscience.org/library/papers/11057778PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8201642

GET https://conductscience.org/api/papers/v1/8201642/authors